Extension Study to Assess Batoclimab in Participants With Thyroid Eye Disease
Status:
Not yet recruiting
Trial end date:
2025-06-01
Target enrollment:
Participant gender:
Summary
This is a 2-cohort (observational and treatment cohort) extension study for participants
completing feeder studies (IMVT-1401-3201 or IMVT-1401-3202). The observational cohort will
assess the durability of proptosis response of feeder studies off treatment. The treatment
cohort will evaluate the efficacy of batoclimab as assessed by proptosis responder rate.